About
Neurocarrus Inc develops targeted protein-based therapies using its proprietary APOLLO delivery platform to treat pain, migraines, and neurodegenerative diseases without causing addiction or systemic side effects.
Explore Neurocarrus Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.